HuGE Literature Finder
Records 1-13
|
Multiple Gene-Environment Interactions on the Angiogenesis Gene-Pathway Impact Rectal Cancer Risk and Survival.
International journal of environmental research and public health 2017 Sep 14 (10): . Sharafeldin Noha, Slattery Martha L, Liu Qi, Franco-Villalobos Conrado, Caan Bette J, Potter John D, Yasui Yuta |
|
Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial.
International journal of cancer 2017 Apr . Schirripa Marta, Zhang Wu, Heinemann Volker, Cao Shu, Okazaki Satoshi, Yang Dongyun, Loupakis Fotios, Berger Martin D, Ning Yan, Miyamoto Yuji, Suenaga Mitsukuni, Gopez Roel F, West Jordan D, Hanna Diana, Barzi Afsaneh, Falcone Alfredo, Stintzing Sebastian, Lenz Heinz-Jos |
|
Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
Pathology oncology research : POR 2017 Feb . Jin Mei, Long Zi-Wen, Yang Jing, Lin Xia |
|
Association of insulin-like growth factor-I receptor polymorphism with colorectal cancer development.
Molecular biology reports 2014 Dec 41 (12): 8099-106. Stanilov Noyko S, Karakolev Iliya A, Deliysky Tashko S, Jovchev Jovcho P, Stanilova Spaska |
|
Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status.
PloS one 2014 9 (8): e103551. Lee Jeeyun, Jain Anjali, Kim Phillip, Lee Tani, Kuller Anne, Princen Fred, In-GuDo , Kim Suk Hyeong, Park Joon Oh, Park Young Suk, Singh Sharat, Kim Hee Che |
|
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.
The pharmacogenomics journal 2011 Dec 11 (6): 437-43. Ho-Pun-Cheung A, Assenat E, Bascoul-Mollevi C, Bibeau F, Boissière-Michot F, Thezenas S, Cellier D, Azria D, Rouanet P, Senesse P, Ychou M, Lopez-Crapez |
|
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?
Clinical colorectal cancer 2011 Dec 10 (4): 325-32. Inno Alessandro, Di Salvatore Mariantonietta, Cenci Tonia, Martini Maurizio, Orlandi Armando, Strippoli Antonia, Ferrara Anna Maria, Bagalà Cinzia, Cassano Alessandra, Larocca Luigi Maria, Barone Car |
|
Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer.
Cancer chemotherapy and pharmacology 2011 Oct 68 (4): 1045-55. Park Jin Hyun, Han Sae-Won, Oh Do-Youn, Im Seock-Ah, Jeong Seung-Yong, Park Kyu Joo, Kim Tae-You, Bang Yung-Jue, Park Jae-Ga |
|
Genes in the insulin and insulin-like growth factor pathway and odds of metachronous colorectal neoplasia.
Human genetics 2011 May 129 (5): 503-12. LeRoy Elizabeth C, Moore Jason H, Hu Chengcheng, Martínez María Elena, Lance Peter, Duggan David, Thompson Patricia |
|
Co-expression of matrix metalloproteinase-7 (MMP-7) and phosphorylated insulin growth factor receptor I (pIGF-1R) correlates with poor prognosis in patients with wild-type KRAS treated with cetuximab or panitumumab: a GEMCAD study.
Cancer biology & therapy 2011 Jan 11 (2): 177-83. Hörndler Carlos, Gallego Rosa, García-Albeniz Xabier, Alonso-Espinaco Virginia, Alonso Vicente, Escudero Pilar, Jimeno Mireya, Ortego Javier, Codony-Servat Jordi, Fernández-Martos Carlos, Calatrava Ana, Marín-Aguilera Mercedes, Muñoz Jenifer, Castellví-Bel Sergi, Castells Antoni, Rubini Michele, Gascón Pere, Maurel Jo |
|
Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Nov 16 (22): 5591-602. Winder Thomas, Zhang Wu, Yang Dongyun, Ning Yan, Bohanes Pierre, Gerger Armin, Wilson Peter M, Pohl Alexandra, Mauro David J, Langer Christiane, Rowinsky Eric K, Lenz Heinz-Jos |
|
Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2010 Aug 20 (4): 305-9. Wernli Karen J, Newcomb Polly A, Wang Yinghui, Makar Karen W, Shadman Mazyar, Chia Victoria M, Burnett-Hartman Andrea, Wurscher Michelle A, Zheng Yingye, Mandelson Margaret |
|
Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.
Mutation research 2009 Jan 660 (1-2): 12-21. Slattery Martha L, Wolff Roger K, Curtin Karen, Fitzpatrick Frank, Herrick Jennifer, Potter John D, Caan Bette J, Samowitz Wade |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 23, 2020
- Content source: